A study in humans demonstrated that the mir-181a-2 was significantly downregulated in the plasma of patients with coronary artery disease compared to normal coronary artery controls, as identified by RNA sequencing and validated by qRT-PCR [Zhong et al. DOI:10.1002/jcla.23020]. In mice, the mir-181a-2 was identified as one of the top 20 most abundant known miRNAs in thymus tissue, and its expression profile was characterized in response to ionizing radiation-induced injury [Chen et al. DOI:10.1080/09553002.2016.1207821]. A study in rhesus macaques demonstrated that the mir-181a-2 was utilized as a feature in elastic net-based models to predict radiation dose, specifically within serum samples collected at Day 6 and Day 15 post whole thorax irradiation [May et al. DOI:10.1038/s41598-022-16316-x].